demonstrated that elimination of PD-1 restriction via targeting the cis-PD-L1-B7-1 duplex effectively alleviated autoimmune disease symptoms in murine models with arthritis, multiple sclerosis, or Sjögren’s syndrome (43). The gene discussed is PDCD1; the disease is autoimmune disease.